J Cancer 2020; 11(13):3783-3793. doi:10.7150/jca.40850 This issue Cite
1. Translational Research Institute, Henan Provincial People's Hospital, Academy of Medical Science, Zhengzhou University, Zhengzhou, 450003, China
2. Biology Department, School of Life Sciences, Anhui Medical University, Hefei, 230032, China
3. Department of Thoracic Surgery, the First Affiliated Hospital, Anhui Medical University, Hefei 230032, China
4. Institute of Medicinal Biotechnology, Jiangsu College of Nursing, Huai'an, 223005, China
*These authors contribute equally to this work.
Esophageal squamous cell carcinoma (ESCC) is a leading malignancy in China with both high incidence and mortality. Towards improving outcomes, clinically-relevant biomarkers are urgently needed for use as prognostic and treatment targets. Herein we applied RNA-seq for deep sequencing of ten matched pairs of ESCC and adjacent non-cancerous tissues (NT) from Chinese patients. Transcriptomic data mapped to approximately 64% of all annotated genes with 2,047 and 708 unigenes being differentially up-regulated and down-regulated, respectively, between ESCCs and NT samples (p<0.05). Dividing cases by pathological grade revealed significant differentially expressed genes (DEG) between ESCC and NT in both low and high differentiation cases (p<0.05) whereas gene expression differences were not significantly different between high and low differentiation ESCC tissues (p=0.053). Moreover, the majority of ESCC and NT tissues formed clusters in principal component analyses. The veracity of the DEG list was validated in a larger cohort of 45 patient samples, with down-regulated CLIC3, up-regulated CLIC4 and unchanged expression of CLIC2 confirmed in ESCC using quantitative PCR and Western blotting. Our data reveal both previously identified ESCC biomarkers along with novel candidates and represent a ready resource of DEGs in ESCC for further investigation.
Keywords: ESCC, transcriptome, differentially expressed gene (DEG), RNA-seq, CLIC2, CLIC3, CLIC4